Covestor’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
Other funds holding PCRX
Covestor's PCRX Position: Q3 2026 in Review
Covestor reduced its Pacira BioSciences (PCRX) stake by 3.3% in Q3 2026, selling an estimated $431 and leaving 491 shares worth $13K. The position accounts for 0.01% of the portfolio, ranked #1308.
Covestor first reported a position in PCRX in Q4 2021 and has held it in 20 quarters since. 258 funds tracked by Wall St. Rank hold PCRX as of Q3 2026.
- Covestor held 491 shares of Pacira BioSciences worth $13K as of Q3 2026.
- Covestor sold 17 Pacira BioSciences shares in Q3 2026, an estimated $431.
- Pacira BioSciences made up 0.01% of Covestor's portfolio in Q3 2026, its #1308 holding.
- Covestor first reported a position in Pacira BioSciences in Q4 2021 and has held it in 20 quarters since.
- 258 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2026.
Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.